AI-powered app could be ‘revolutionary’ for cystic fibrosis patients
An app that uses artificial intelligence (AI) could be “revolutionary” for patients with chronic lung conditions such as cystic fibrosis, with the technology able to predict when a patient will fall ill up to 10 days in advance.
It is hoped Breathe RM will allow patients with cystic fibrosis (CF) to be monitored remotely, removing the need for regular wellness checks in clinics.
The technology can also predict when patients are likely to get a major infection – known as an exacerbation – which can lead to weeks in hospital.
It is being trialled at with support from medical research charity LifeArc and and the National Institute for Health and Care Research (NIHR).
